2025
Advance care planning documentation prior to end-of-life systemic therapy: A single institution retrospective review.
Xiang J, Wiese B, Patlovich K, Taylor J, Adelson K, Ratan R. Advance care planning documentation prior to end-of-life systemic therapy: A single institution retrospective review. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e24031.Peer-Reviewed Original ResearchSystemic anticancer therapyMonths of lifeTargeted therapyDose of treatmentAdvance care planning notesFinal treatmentAdvance care planningEnd-of-lifeHigher risk of mortalityDocumented discussionAssociated with decreased quality of lifeRisk of mortalityAssociated with decreased qualityMetastatic diseaseHigh healthcare useInpatient settingSolid tumorsRetrospective studyMD AndersonCellular therapyMedical oncologistsAnticancer therapyImmunotherapyTherapyPatientsPotential Protective Role of Diabetes Mellitus on Aortic Aneurysms
Epstein E, Elefteriades J. Potential Protective Role of Diabetes Mellitus on Aortic Aneurysms. Aorta 2025, 13: 039-045. PMID: 40759177, PMCID: PMC12472811, DOI: 10.1055/a-2624-0594.Peer-Reviewed Original ResearchThoracic aortic aneurysmAbdominal aortic aneurysmGrowth of abdominal aortic aneurysmsAortic aneurysmDiabetes mellitusRisk of mortalityPotential protective roleAbdominal aortic aneurysm repairHigh riskAbdominal aortic aneurysm ruptureD-dimer levelsHigher risk of mortalityStatistically significant differenceDiabetic aortaDiabetes protectionAneurysm diameterD-dimerLower homocysteineAneurysmLow riskPatientsMellitusSignificant differenceProtective effectMortalityPhoenix Sepsis Criteria in Critically Ill Children: Retrospective Validation Using a United States Nine-Center Dataset, 2012–2018
Sanchez-Pinto L, Daniels L, Atreya M, Faustino E, Farris R, Geva A, Khemani R, Rogerson C, Shah S, Weiss S, Bennett T. Phoenix Sepsis Criteria in Critically Ill Children: Retrospective Validation Using a United States Nine-Center Dataset, 2012–2018. Pediatric Critical Care Medicine 2025, 26: e155-e165. PMID: 39982153, PMCID: PMC11792981, DOI: 10.1097/pcc.0000000000003675.Peer-Reviewed Original ResearchConceptsInternational Pediatric Sepsis Consensus ConferenceInternational Pediatric Sepsis Consensus Conference criteriaPhoenix criteriaCritically Ill ChildrenSepsis criteriaPICU admissionCohort of critically ill childrenOrgan dysfunction scoreIll childrenMulticenter cohort studyHigher risk of mortalityMortality of patientsAge groupsIn-Hospital MortalityRisk of mortalitySeverity of illnessDiscrimination of mortalityBloodstream infectionsSuspected infectionMulticenter cohortSeptic shockSepsis scoreDysfunction scorePatient subgroupsRetrospective analysis
2024
Recipient functional status impacts on short and long-term intestinal transplant outcomes in United States adults
Boateng S, Ameyaw P, Gyabaah S, Adjepong Y, Njei B. Recipient functional status impacts on short and long-term intestinal transplant outcomes in United States adults. World Journal Of Transplantation 2024, 14: 93561. PMID: 39295973, PMCID: PMC11317861, DOI: 10.5500/wjt.v14.i3.93561.Peer-Reviewed Original ResearchIntestinal transplant outcomesMedian survival timeTransplant outcomesSurvival outcomesFunctional statusUnited States adultsPost-transplant survival outcomesSurvival timeMultivariate Cox regressionPoor survival outcomesKaplan-Meier curvesKarnofsky performance statusFunctional impairmentHigher risk of mortalityRetrospective cohort studyPost-transplant outcomesSevere impairmentRisk of mortalityImpact post-transplant outcomesSevere functional impairmentMedian agePerformance statusPrognostic indicatorIntestinal transplantationKidney transplantation
2023
Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure
Kim M, Aseltine R, Tabtabai S. Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 681. DOI: 10.1016/j.cardfail.2022.10.335.Peer-Reviewed Original ResearchDiagnosis of HFNational Readmission DatabaseRenal failureRisk scoreCohort of HF patientsHigh riskMultivariate logistic regression analysisReadmission ratesAssociated with younger ageHigher risk of mortalityAdmitted with HFCompared patient demographicsChronic pulmonary diseasePopulation of patientsMultivariate logistic regressionThirty-day readmission ratesLogistic regression analysisElixhauser comorbiditiesRisk of mortalityReadmission riskEvidence-based clinical decision supportHigher risk of readmissionDeficiency anemiaPatient demographicsRisk of readmission
2022
Associations of Dysnatremia with COVID-19 Status and Mortality
Liu D, Mowrey W, Fisher M, Basalely A, McCarthy J, Kumar N, Thakkar J, Azzi Y, Brogan M, Golestaneh L, Reidy K, Chen W. Associations of Dysnatremia with COVID-19 Status and Mortality. Kidney360 2022, 3: 1323-1331. PMID: 36176656, PMCID: PMC9416846, DOI: 10.34067/kid.0001062022.Peer-Reviewed Original ResearchConceptsPrevalence of hypernatremiaAssociated with mortalityAssociation of dysnatremiaCOVID-19 statusAssociated with high mortalityCOVID-19-negative patientsMedian Follow-UpTertiary care centerHigher risk of mortalityRetrospective observational studyCox proportional hazards modelsAssociated with hypernatremiaCOVID-19 positive patientsRisk of mortalityProportional hazards model
2020
Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
Lee K, Kim J, Hong S, Seong D, Choi Y, Ahn Y, Kim K, Kim S, Lee S, Sim W, Kim D, Jun B, Yang J, Yon D, Lee S, Kim M, Dragioti E, Li H, Jacob L, Koyanagi A, Abou Ghayda R, Shin J, Smith L. Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles. European Review For Medical And Pharmacological Sciences 2020, 24: 13089-13097. PMID: 33378062, DOI: 10.26355/eurrev_202012_24216.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAsian PeopleBlack PeopleCoronary Artery DiseaseCOVID-19COVID-19 Drug TreatmentDatabases, FactualDiabetes MellitusDrug Therapy, CombinationEnzyme InhibitorsHeart FailureHumansHydroxychloroquineHypertensionImmunocompromised HostInformation DisseminationMacrolidesObesityOrgan Dysfunction ScoresProtective FactorsPulmonary Disease, Chronic ObstructiveRandomized Controlled Trials as TopicRetraction of Publication as TopicRisk FactorsSARS-CoV-2Severity of Illness IndexSex FactorsSmokingConceptsAssociated with higher risk of mortalityAssociated with higher riskHigher risk of mortalityAngiotensin receptor blockersRisk of mortalityAngiotensin-converting enzyme inhibitorsAssociated with reduced riskAngiotensin-converting enzymeSystematic reviewRisk factorsCombination therapyCOVID-19 mortalityAssociated with reduced risk of mortalityCombination therapy of hydroxychloroquineSystematic review of randomized controlled trialsReview of randomized controlled trialsRelevant cohort studiesClinical risk factorsClinical issuesRandomized Controlled TrialsCOVID-19 patientsReceptor blockersCohort studyControlled TrialsCOVID-19Body Mass Index and Mortality in Blunt Trauma: The Right BMI can be Protective
Choi J, Smiley A, Latifi R, Gogna S, Prabhakaran K, Con J, Anderson P, Policastro A, Beydoun M, Rhee P. Body Mass Index and Mortality in Blunt Trauma: The Right BMI can be Protective. The American Journal Of Surgery 2020, 220: 1475-1479. PMID: 33109335, DOI: 10.1016/j.amjsurg.2020.10.017.Peer-Reviewed Original ResearchConceptsNon-elderly patientsTrauma Quality Improvement ProgramInjury Severity ScoreAssociated with mortalityBlunt traumaAssociation of mortalityQuality Improvement ProgramBody mass indexHigher risk of mortalityRisk of mortalityBlunt traumatic injuryBMI rangeGeneralized additive modelHigher BMIObesity paradoxMass indexMorbid obesityRetrospective studyTrauma populationBMISeverity scoreHigh riskImprovement programsPatientsProtective factors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply